Skip to the page

Data / Drug companies / Ipca Laboratories Limited

Ipca Laboratories Limited: 54 products in the FDA NDC directory, labeler code 57451

Ipca Laboratories Limited (labeler code 57451) lists 54 products in the FDA National Drug Code Directory. By type: 54 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on October 3, 2025.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
57451
Products in commercial distribution
54
Packages
64
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
0
Earliest marketing start
November 30, 2007
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients54100%

Products by type

TypeProductsShare
Bulk ingredients54100%

Dosage forms

Dosage formProductsShare
Powder54100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Atovaquone57451-1227PowderBulk ingredientsOctober 3, 2025
Etodolac57451-1232PowderBulk ingredientsMarch 19, 2025
Bupropion hydrochloride57451-1213PowderBulk ingredientsDecember 27, 2024
Losartan potassium57451-1211PowderBulk ingredientsDecember 27, 2024
Hydroxyzine pamoate57451-1228PowderBulk ingredientsDecember 26, 2024
Hydrochlorothiazide57451-1142PowderBulk ingredientsDecember 1, 2023
Hydroxyzine hydrochloride57451-1219PowderBulk ingredientsDecember 19, 2022
Meloxicam57451-1218PowderBulk ingredientsDecember 19, 2022
Pyrantel pamoate57451-1233PowderBulk ingredientsJuly 22, 2022
Propranolol hydrochloride57451-1216PowderBulk ingredientsJune 17, 2021
Valsartan57451-1172PowderBulk ingredientsDecember 6, 2019
Venlafaxine hydrochloride57451-1207PowderBulk ingredientsDecember 4, 2019
Pyrimethamine57451-1183PowderBulk ingredientsNovember 12, 2019
Metoprolol tartrate57451-1163PowderBulk ingredientsNovember 8, 2019
Amlodipine besylate57451-1188PowderBulk ingredientsNovember 6, 2019
Ondansetron hydrochloride57451-1153PowderBulk ingredientsNovember 4, 2019
Benzocaine57451-1215PowderBulk ingredientsSeptember 30, 2014
Benzocaine57451-1215PowderBulk ingredientsSeptember 30, 2014
Hydroxyzine hydrochloride57451-1184PowderBulk ingredientsOctober 26, 2013
Chorthalidone57451-1134PowderBulk ingredientsOctober 26, 2013
Alendronate acid57451-1157PowderBulk ingredientsAugust 16, 2013
Etodolac57451-1161PowderBulk ingredientsJuly 24, 2013
Quetiapine hemifumarate57451-1159PowderBulk ingredientsJuly 11, 2013
Mesalamine57451-1141PowderBulk ingredientsJuly 11, 2013
Midodrine hydrochloride57451-1204PowderBulk ingredientsJuly 8, 2013

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.